Found 3 hits for monomerid = 50215745 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50215745
(CHEMBL245966 | N-ethyl-5-(2-(3-(6-methoxy-1H-benzo...)Show SMILES CCNC(=O)c1cncc(C=Cc2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1 |w:10.9| Show InChI InChI=1S/C21H20N6O2/c1-3-23-21(28)15-8-13(10-22-11-15)4-5-14-12-24-27-19(14)20-25-17-7-6-16(29-2)9-18(17)26-20/h4-12H,3H2,1-2H3,(H,23,28)(H,24,27)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |
Receptor tyrosine-protein kinase erbB-2
(Homo sapiens (Human)) | BDBM50215745
(CHEMBL245966 | N-ethyl-5-(2-(3-(6-methoxy-1H-benzo...)Show SMILES CCNC(=O)c1cncc(C=Cc2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1 |w:10.9| Show InChI InChI=1S/C21H20N6O2/c1-3-23-21(28)15-8-13(10-22-11-15)4-5-14-12-24-27-19(14)20-25-17-7-6-16(29-2)9-18(17)26-20/h4-12H,3H2,1-2H3,(H,23,28)(H,24,27)(H,25,26) | PDB MMDB
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of HER2 |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |
Aurora kinase A
(Homo sapiens (Human)) | BDBM50215745
(CHEMBL245966 | N-ethyl-5-(2-(3-(6-methoxy-1H-benzo...)Show SMILES CCNC(=O)c1cncc(C=Cc2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1 |w:10.9| Show InChI InChI=1S/C21H20N6O2/c1-3-23-21(28)15-8-13(10-22-11-15)4-5-14-12-24-27-19(14)20-25-17-7-6-16(29-2)9-18(17)26-20/h4-12H,3H2,1-2H3,(H,23,28)(H,24,27)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of aurora-A |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |